51 related articles for article (PubMed ID: 20395114)
1. In vitro and in vivo evidence of pathogenic roles of Hic-5/ARA55 in keloids through Smad pathway and profibrotic transcription.
Inui S; Shono F; Noguchi F; Nakajima T; Hosokawa K; Itami S
J Dermatol Sci; 2010 May; 58(2):152-4. PubMed ID: 20395114
[No Abstract] [Full Text] [Related]
2. Comparison of transforming growth factor-beta/Smad signaling between normal dermal fibroblasts and fibroblasts derived from central and peripheral areas of keloid lesions.
Tsujita-Kyutoku M; Uehara N; Matsuoka Y; Kyutoku S; Ogawa Y; Tsubura A
In Vivo; 2005; 19(6):959-63. PubMed ID: 16277007
[TBL] [Abstract][Full Text] [Related]
3. Selective inhibition of activin receptor-like kinase 5 signaling blocks profibrotic transforming growth factor beta responses in skin fibroblasts.
Mori Y; Ishida W; Bhattacharyya S; Li Y; Platanias LC; Varga J
Arthritis Rheum; 2004 Dec; 50(12):4008-21. PubMed ID: 15593186
[TBL] [Abstract][Full Text] [Related]
4. Studies of transforming growth factors beta 1-3 and their receptors I and II in fibroblast of keloids and hypertrophic scars.
Bock O; Yu H; Zitron S; Bayat A; Ferguson MW; Mrowietz U
Acta Derm Venereol; 2005; 85(3):216-20. PubMed ID: 16040405
[TBL] [Abstract][Full Text] [Related]
5. Disruption of transforming growth factor beta signaling and profibrotic responses in normal skin fibroblasts by peroxisome proliferator-activated receptor gamma.
Ghosh AK; Bhattacharyya S; Lakos G; Chen SJ; Mori Y; Varga J
Arthritis Rheum; 2004 Apr; 50(4):1305-18. PubMed ID: 15077315
[TBL] [Abstract][Full Text] [Related]
6. A novel truncated TGF-beta receptor II downregulates collagen synthesis and TGF-beta I secretion of keloid fibroblasts.
Chu Y; Guo F; Li Y; Li X; Zhou T; Guo Y
Connect Tissue Res; 2008; 49(2):92-8. PubMed ID: 18382895
[TBL] [Abstract][Full Text] [Related]
7. Significant downregulation of transforming growth factor-beta signal transducers in human skin following ultraviolet-A1 irradiation.
Gambichler T; Skrygan M; Tomi NS; Breuksch S; Altmeyer P; Kreuter A
Br J Dermatol; 2007 May; 156(5):951-6. PubMed ID: 17381457
[TBL] [Abstract][Full Text] [Related]
8. [Effects of interferon-gamma on the transforming growth factor beta/Smad pathway in keloid-derived fibroblasts].
Liu JQ; Hu DH; Zhang ZF; Guan H; She T; Zhang J; Bai XZ
Zhonghua Shao Shang Za Zhi; 2009 Dec; 25(6):454-9. PubMed ID: 20193171
[TBL] [Abstract][Full Text] [Related]
9. Rapamycin induces the TGFbeta1/Smad signaling cascade in renal mesangial cells upstream of mTOR.
Osman B; Doller A; Akool el-S; Holdener M; Hintermann E; Pfeilschifter J; Eberhardt W
Cell Signal; 2009 Dec; 21(12):1806-17. PubMed ID: 19666112
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of the Wnt/beta-catenin pathway induced by transforming growth factor-beta in hypertrophic scars and keloids.
Sato M
Acta Derm Venereol; 2006; 86(4):300-7. PubMed ID: 16874413
[TBL] [Abstract][Full Text] [Related]
11. Smad3 signalling plays an important role in keloid pathogenesis via epithelial-mesenchymal interactions.
Phan TT; Lim IJ; Aalami O; Lorget F; Khoo A; Tan EK; Mukhopadhyay A; Longaker MT
J Pathol; 2005 Oct; 207(2):232-42. PubMed ID: 16052471
[TBL] [Abstract][Full Text] [Related]
12. Fibroblast expression of the coactivator p300 governs the intensity of profibrotic response to transforming growth factor beta.
Bhattacharyya S; Ghosh AK; Pannu J; Mori Y; Takagawa S; Chen G; Trojanowska M; Gilliam AC; Varga J
Arthritis Rheum; 2005 Apr; 52(4):1248-58. PubMed ID: 15818659
[TBL] [Abstract][Full Text] [Related]
13. Expression of transforming growth factor beta 1, 2, and 3 proteins in keloids.
Lee TY; Chin GS; Kim WJ; Chau D; Gittes GK; Longaker MT
Ann Plast Surg; 1999 Aug; 43(2):179-84. PubMed ID: 10454326
[TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor beta (TGFbeta) and keloid disease.
Jagadeesan J; Bayat A
Int J Surg; 2007 Aug; 5(4):278-85. PubMed ID: 17660136
[TBL] [Abstract][Full Text] [Related]
15. A novel mechanism by which hepatocyte growth factor blocks tubular epithelial to mesenchymal transition.
Yang J; Dai C; Liu Y
J Am Soc Nephrol; 2005 Jan; 16(1):68-78. PubMed ID: 15537870
[TBL] [Abstract][Full Text] [Related]
16. Expression and regulation of intracellular SMAD signaling in scleroderma skin fibroblasts.
Mori Y; Chen SJ; Varga J
Arthritis Rheum; 2003 Jul; 48(7):1964-78. PubMed ID: 12847691
[TBL] [Abstract][Full Text] [Related]
17. Cyclic adenosine 3',5'-monophosphate-elevating agents inhibit transforming growth factor-beta-induced SMAD3/4-dependent transcription via a protein kinase A-dependent mechanism.
Schiller M; Verrecchia F; Mauviel A
Oncogene; 2003 Dec; 22(55):8881-90. PubMed ID: 14654784
[TBL] [Abstract][Full Text] [Related]
18. Smad3/AP-1 interactions control transcriptional responses to TGF-beta in a promoter-specific manner.
Verrecchia F; Vindevoghel L; Lechleider RJ; Uitto J; Roberts AB; Mauviel A
Oncogene; 2001 Jun; 20(26):3332-40. PubMed ID: 11423983
[TBL] [Abstract][Full Text] [Related]
19. Fibroblasts from chronic wounds show altered TGF-beta-signaling and decreased TGF-beta Type II receptor expression.
Kim BC; Kim HT; Park SH; Cha JS; Yufit T; Kim SJ; Falanga V
J Cell Physiol; 2003 Jun; 195(3):331-6. PubMed ID: 12704642
[TBL] [Abstract][Full Text] [Related]
20. Alteration of the TGF-beta/SMAD pathway in intrinsically and UV-induced skin aging.
Han KH; Choi HR; Won CH; Chung JH; Cho KH; Eun HC; Kim KH
Mech Ageing Dev; 2005 May; 126(5):560-7. PubMed ID: 15811425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
